Skip to main content
Log in

Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The effects of gestational diabetes mellitus (GDM) were determined on urinary excretion of putative components of insulin signaling. Random urine samples were collected from 375 gravidas at 6 to 14 weeks’ gestation, 22 to 32 weeks’ gestation, and ∼6 weeks’ postpartum. Gestational diabetes mellitus developed in 35 women who were matched with 59 normal gravidas. Urinary concentrations of myo-inositol (MI) and D-chiro-inositol (DCI) were measured by gas chromatography/mass spectrometry and normalized to creatinine levels. Compared to postpartum values, urinary excretion of MI and DCI was increased 2.9-fold and 2-fold, respectively, in early pregnancy, and 5.5-fold and 4.5-fold, respectively, in later gestation. Gravidas with GDM had significantly greater MI and DCI excretion than controls in the first trimester but not subsequently. The results suggest that gravidas destined to develop GDM have altered synthesis, metabolism, and/or renal excretion of MI and DCI in early pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Catalano PM, Tybir ED, Roman NM, Amini SB, Sims EA. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165(6 pt 1): 1667–1672.

    CAS  PubMed  Google Scholar 

  2. Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010;140(3):365–371.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Kautzky-Willer A, Bancher-Todesca D. Endocrine changes in diabetic pregnancy. In: Djelmiš J, Ivanišević M, eds. Diabetology of Pregnancy, Frontiers in Diabetes. Vol 17. Basel, Switzerland: Karger Medical and Scientific Publishers; 2005;18–33.

    Google Scholar 

  4. Yen SSC, Tsai CC, Vela P. Gestational diabetogenesis: quantitative analyses of glucose-insulin interrelationship between normal pregnancy and pregnancy with gestational diabetes. Am J Obstet Gynecol. 1971;111(6):792–800.

    CAS  PubMed  Google Scholar 

  5. Bowes SB, Hennessy TR, Umpleby AM, et al. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia. 1996;39(8):976–983.

    CAS  PubMed  Google Scholar 

  6. Homko C, Sivan E, Chen X, Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001;86(2):568–573.

    CAS  PubMed  Google Scholar 

  7. Larner J, Brautigan DL, Thorner MO. D-Chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010;16(11–12):543–551.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Larner J. D-chiro-inositol—its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res. 2002;3(1):47–60.

    PubMed  PubMed Central  Google Scholar 

  9. Ortmeyer HK, Bodkin N, Hansen BC, Larner J. In vivo D-chiroinositol activates skeletal muscle glycogen synthase and inactivates glycogen phosphorylase in rhesus monkeys. Nutr Biochem. 1995;6(9):499–503.

    CAS  Google Scholar 

  10. Rademacher TW, Caro H, Kunjara S, Wang DY, Greenbaum AL, McLean P. Inositolphosphoglycan second messengers. Braz J Med Biol Res. 1994;27(2):327–341.

    CAS  PubMed  Google Scholar 

  11. Saltiel AR. Second messengers of insulin action. Diabetes Care. 1990;13(3):244–256.

    CAS  PubMed  Google Scholar 

  12. Daughaday WH, Larner J. The renal excretion of inositol in normal and diabetic human beings. J Clin Invest. 1954;33(3):326–332.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Hong JH, Jang HW, Kang YE, et al. Urinary chiro- and myoinositol levels as a biological marker for type 2 diabetes mellitus. Dis Markers. 2012;33(4):193–199.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Jung TS, Hahm JR, Kim JJ, et al. Determination of urinary Myo-/ chiro-inositol ratios from Korean diabetes patients. Yonsei Med J. 2005;46(4):532–538.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Larner J, Craig JW. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care. 1996;19(1):76–78.

    CAS  PubMed  Google Scholar 

  16. Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR. D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993;90(21):9988–9992.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Kennington AS, Hill CR, Craig J, et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1990;323(6):373–378.

    CAS  PubMed  Google Scholar 

  18. Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE Jr, Apridonidze T, Iuorno MJ, Nestler JE. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care. 2006;29(2):300–305.

    CAS  PubMed  Google Scholar 

  19. Baillargeon JP, Nestler JE, Ostlund RE, Apridonidze T, Diamanti-Kandarakis E. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Hum Reprod. 2008;23(6):1439–1446.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Stull AJ, Thyfault JP, Haub MD, Ostlund RE, Campbell WW. Relationship between urinary inositol excretions and wholebody glucose tolerance and skeletal muscle insulin receptor phosphorylation. Metabolism. 2008;57(11):1545–1551.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–773.

    CAS  PubMed  Google Scholar 

  22. Davison JM, Dunlop W. Renal hemodynamic and tubular function in normal human pregnancy. Kidney Int. 1980;18(2): 152–161.

    CAS  PubMed  Google Scholar 

  23. Davison JM. Overview: kidney function in pregnant women. Am J Kid Dis. 1987;9(4):248–252.

    CAS  PubMed  Google Scholar 

  24. Lin X, Ma L, Fitzgerald RL, Ostlund RE. Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells. Arch Biochem Biophys. 2009;481(2):197–201.

    CAS  PubMed  Google Scholar 

  25. Lahjouji K, Aouameur R, Bissonnette P, Coady MJ, Bichet DG, Lapointe JY. Expression and functionality of the Na+/myoinositol cotransporter SMIT2 in rabbit kidney. Biochem Biophys Acta. 2007;1768(5):1154–1159.

    CAS  PubMed  Google Scholar 

  26. Lind T, Hytten FE. The excretion of glucose during normal pregnancy. J Obstet Gynaecol Br Commonw. 1972;79(11): 961–965.

    CAS  PubMed  Google Scholar 

  27. Scioscia M, Pesci A, Zamboni G, Huppertz B, Resta L. D-chiroinositol phosphoglycan expression in human placenta at term in diabetes. Arch Gynecol Obstet. 2013;288(2):459–460.

    PubMed  Google Scholar 

  28. Scioscia M, Gumaa K, Selvaggi LE, Rodeck CH, Rademacher TW. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes. J Perinat Med. 2009;37(5):469–471.

    CAS  PubMed  Google Scholar 

  29. Scioscia M, Kunjara S, Gumaa K, et al. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecol Obstet Invest. 2007;64(4):217–223.

    CAS  PubMed  Google Scholar 

  30. Asplin I, Galasko G, Larner J. Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myoinositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci U S A. 1993;90(13):5924–5928.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Kawa JM, Przybylski R, Taylor CG. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozocin diabetic rat. Exp Bio Med. 2003;228(8):907–914.

    CAS  Google Scholar 

  32. Sun T, Heimark D, Nguygen T, Nadler J, Larner J. Both myoinositol to chiro-inositol epimerase activities and chiro-inositol and to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem Biophys Res Commun. 2002;293(3):1092–1098.

    CAS  PubMed  Google Scholar 

  33. Ostlund RE Jr, Sherman WR. Measurement of D-chiro-inositol in clinical studies. Diabetes Care. 1995;18(7):1074–1075.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aisling Murphy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murphy, A., Shamshirsaz, A., Markovic, D. et al. Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus. Reprod. Sci. 23, 365–371 (2016). https://doi.org/10.1177/1933719115602767

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719115602767

Keywords

Navigation